Epigral Balance Sheet Health
Financial Health criteria checks 3/6
Epigral has a total shareholder equity of ₹14.0B and total debt of ₹9.0B, which brings its debt-to-equity ratio to 63.9%. Its total assets and total liabilities are ₹29.8B and ₹15.8B respectively. Epigral's EBIT is ₹5.1B making its interest coverage ratio 6.7. It has cash and short-term investments of ₹60.8M.
Key information
63.9%
Debt to equity ratio
₹8.95b
Debt
| Interest coverage ratio | 6.7x |
| Cash | ₹60.80m |
| Equity | ₹14.00b |
| Total liabilities | ₹15.79b |
| Total assets | ₹29.79b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543332's short term assets (₹6.7B) do not cover its short term liabilities (₹8.5B).
Long Term Liabilities: 543332's short term assets (₹6.7B) do not cover its long term liabilities (₹7.3B).
Debt to Equity History and Analysis
Debt Level: 543332's net debt to equity ratio (63.5%) is considered high.
Reducing Debt: 543332's debt to equity ratio has reduced from 85.3% to 63.9% over the past 5 years.
Debt Coverage: 543332's debt is well covered by operating cash flow (48.3%).
Interest Coverage: 543332's interest payments on its debt are well covered by EBIT (6.7x coverage).